Clinical Trial Update: Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports results from Phase 1/2 trials evaluating a three-drug regimen of cyclophosphamide, abatacept, and tacrolimus for prevention o…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Drugs mentioned

• Abatacept (abatacept)
• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: NYU Langone Health | Conditions: Graft-versus-host Disease | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-11-08